Literature DB >> 1671823

Are diprotin A (Ile-Pro-Ile) and diprotin B (Val-Pro-Leu) inhibitors or substrates of dipeptidyl peptidase IV?

J Rahfeld1, M Schierhorn, B Hartrodt, K Neubert, J Heins.   

Abstract

Dipeptidyl peptidase IV preferably hydrolyzes peptides and proteins with a penultimate proline residue. Umezawa and co-workers (Umezawa et al. (1984) J. Antibiotics 37, 422-425) reported that diprotin A (Ile-Pro-Ile) and diprotin B (Val-Pro-Leu) are inhibitors for dipeptidyl peptidase IV. We could show that both compounds as well as other tripeptides with a penultimate proline residue are substrates for dipeptidyl peptidase IV. An apparent competitive inhibition by those compounds is a kinetic artifact due to the substrate-like structure of such tripeptides.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1671823     DOI: 10.1016/0167-4838(91)90284-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Structure of the unliganded form of the proprotein convertase furin suggests activation by a substrate-induced mechanism.

Authors:  Sven O Dahms; Marcelino Arciniega; Torsten Steinmetzer; Robert Huber; Manuel E Than
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-19       Impact factor: 11.205

2.  Periplasmic form of dipeptidyl aminopeptidase IV from Pseudoxanthomonas mexicana WO24: purification, kinetic characterization, crystallization and X-ray crystallographic analysis.

Authors:  Saori Roppongi; Chika Tateoka; Mayu Fujimoto; Ippei Iizuka; Saori Morisawa; Akihiro Nakamura; Nobuyuki Honma; Yoshiyuki Suzuki; Yosuke Shida; Wataru Ogasawara; Nobutada Tanaka; Yasumitsu Sakamoto; Takamasa Nonaka
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2017-10-23       Impact factor: 1.056

3.  Glypican-3-mediated inhibition of CD26 by TFPI: a novel mechanism in hematopoietic stem cell homing and maintenance.

Authors:  Satish Khurana; Lia Margamuljana; Chacko Joseph; Sarah Schouteden; Shannon M Buckley; Catherine M Verfaillie
Journal:  Blood       Date:  2013-01-17       Impact factor: 22.113

4.  Dipeptidyl peptidase IV is a human and murine neutrophil chemorepellent.

Authors:  Sarah E Herlihy; Darrell Pilling; Anu S Maharjan; Richard H Gomer
Journal:  J Immunol       Date:  2013-05-15       Impact factor: 5.422

5.  SDF-1 dynamically mediates megakaryocyte niche occupancy and thrombopoiesis at steady state and following radiation injury.

Authors:  Lisa M Niswander; Katherine H Fegan; Paul D Kingsley; Kathleen E McGrath; James Palis
Journal:  Blood       Date:  2014-04-15       Impact factor: 22.113

6.  Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage.

Authors:  T Oravecz; M Pall; G Roderiquez; M D Gorrell; M Ditto; N Y Nguyen; R Boykins; E Unsworth; M A Norcross
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

7.  Dipeptidyl peptidase IV as a potential target for selective prodrug activation and chemotherapeutic action in cancers.

Authors:  Arik Dahan; Omri Wolk; Peihua Yang; Sachin Mittal; Zhiqian Wu; Christopher P Landowski; Gordon L Amidon
Journal:  Mol Pharm       Date:  2014-11-13       Impact factor: 4.939

8.  Crystal structures of a bacterial dipeptidyl peptidase IV reveal a novel substrate recognition mechanism distinct from that of mammalian orthologues.

Authors:  Saori Roppongi; Yoshiyuki Suzuki; Chika Tateoka; Mayu Fujimoto; Saori Morisawa; Ippei Iizuka; Akihiro Nakamura; Nobuyuki Honma; Yosuke Shida; Wataru Ogasawara; Nobutada Tanaka; Yasumitsu Sakamoto; Takamasa Nonaka
Journal:  Sci Rep       Date:  2018-02-09       Impact factor: 4.379

Review 9.  The opioid effects of gluten exorphins: asymptomatic celiac disease.

Authors:  Leo Pruimboom; Karin de Punder
Journal:  J Health Popul Nutr       Date:  2015-11-24       Impact factor: 2.000

10.  Glial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropatic pain.

Authors:  Kornél Király; Márk Kozsurek; Erika Lukácsi; Benjamin Barta; Alán Alpár; Tamás Balázsa; Csaba Fekete; Judit Szabon; Zsuzsanna Helyes; Kata Bölcskei; Valéria Tékus; Zsuzsanna E Tóth; Károly Pap; Gábor Gerber; Zita Puskár
Journal:  Sci Rep       Date:  2018-02-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.